caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1588970727

Bashar HmoudM.D.

GastroenterologyGarden City, MII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
69.4
Quality
89.9
Cost
78.2
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-0.67%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$17
Payment records
1
By payment type
Food and Beverage$17
PRESCRIBING · PART D · 2024
Total Rx claims
306
Beneficiaries
—
Total drug cost
$69K
Distinct drugs
5
Brand share
19.0%
Top prescribed drugs
Pantoprazole Sodium168 claims
Linaclotide58 claims
Omeprazole49 claims
Ursodiol19 claims
Metronidazole12 claims
REFERRAL NETWORK

Where Bashar Hmoud's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Sreeram Parupudi
Gastroenterology · Galveston, TX
3052
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
906
Unique beneficiaries
—
Total services
1,380
Distinct HCPCS
16
Medicare payment
$131K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 386 Gastroenterology providers in MI — top quintile (cohort median 472).